Yale researchers identified an underactive mTOR pathway as a cause of lissencephaly and reversed brain malformations in patient-derived organoids using a drug. This breakthrough may offer a treatment path for the entire spectrum of lissencephaly disorders. Lissencephaly is a rare spectrum of genetic disorders characterized by the brain’s failure to form its typical folds. These […]